Beatriz
Ramirez Sola
Investigadora
Publicacions en què col·labora amb Beatriz Ramirez Sola (22)
2018
-
Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities
Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589
2017
-
Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes
International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387
-
IL-32α-induced inflammation constitutes a link between obesity and colon cancer
OncoImmunology, Vol. 6, Núm. 7
2016
2015
-
Expression of S6K1 in human visceral adipose tissue is upregulated in obesity and related to insulin resistance and inflammation
Acta Diabetologica, Vol. 52, Núm. 2, pp. 257-266
2014
-
Activation of noncanonical wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation
Journal of Clinical Endocrinology and Metabolism, Vol. 99, Núm. 8
-
Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans
Surgical Endoscopy, Vol. 28, Núm. 8, pp. 2412-2420
2013
-
Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: Tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients
Surgery for Obesity and Related Diseases, Vol. 9, Núm. 2, pp. 306-314
-
Six-transmembrane epithelial antigen of prostate 4 and neutrophil gelatinase-associated lipocalin expression in visceral adipose tissue is related to iron status and inflammation in human obesity
European Journal of Nutrition, Vol. 52, Núm. 6, pp. 1587-1595
2012
-
Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity
International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294
-
Clinical usefulness of a new equation for estimating body fat
Diabetes Care, Vol. 35, Núm. 2, pp. 383-388
-
Estudio de la utilidad de la bioimpedancia en la determinación de la grasa visceral y su aplicación en el diagnóstico y tratamiento de la obesidad y sus comorbilidades
Anales del sistema sanitario de Navarra, Vol. 35, Núm. 1, pp. 183-184
-
Increased tenascin C and toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity
Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 10
2011
-
Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity
Nutrition, Metabolism and Cardiovascular Diseases, Vol. 21, Núm. 4, pp. 245-253
-
Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI
Obesity, Vol. 19, Núm. 7, pp. 1439-1444
-
Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass
Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 1, pp. 200-209
-
Increased levels of calprotectin in obesity are related to macrophage content: Impact on inflammation and effect of weight loss
Molecular Medicine, Vol. 17, Núm. 11, pp. 1157-1167
-
Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer
Journal of Nutritional Biochemistry, Vol. 22, Núm. 7, pp. 634-641
2009
-
Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans
Journal of Molecular Medicine, Vol. 87, Núm. 8, pp. 803-813
2008
-
Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass
Clinical Endocrinology, Vol. 69, Núm. 2, pp. 208-215